Back to GetFilings.com



Table of Contents

 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form 10-Q
     
þ
  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the quarterly period ended March 31, 2005
 
or
 
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the transition period from           to           .
Commission file number: 0-28074
Sapient Corporation
(Exact name of registrant as specified in its charter)
     
Delaware
  04-3130648
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
 
25 First Street,
Cambridge, MA
(Address of principal executive offices)
  02141
(Zip Code)
617-621-0200
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
      Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     þ Yes          o No
      Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).     þ Yes          o No
      As of May 2, 2005, there were 124,032,488 shares of the Company’s common stock outstanding.
 
 


SAPIENT CORPORATION
INDEX
             
        Page
        Number
         
PART I. FINANCIAL INFORMATION
Item 1.
  Financial Statements (Unaudited)        
     Consolidated and Condensed Balance Sheets as of March 31, 2005 and
December 31, 2004
    2  
     Consolidated and Condensed Statements of Operations for the Three Months Ended
March 31, 2005 and 2004
    3  
     Consolidated and Condensed Statements of Cash Flows for the Three Months Ended
March 31, 2005 and 2004
    4  
     Notes to Consolidated and Condensed Financial Statements     5  
   Management’s Discussion and Analysis of Financial Condition and Results of Operations     13  
   Quantitative and Qualitative Disclosures About Market Risk     31  
   Controls and Procedures     31  
 
 PART II. OTHER INFORMATION
   Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities     33  
   Other Information     33  
   Exhibits     34  
 Signatures     35  
 EX-10.5 2005 Global Bonus Plan
 EX-31.1 Section 302 Certification of Jerry Greenberg
 EX-32.2 Section 302 Certification of Stuart Moore
 EX-31.1 Section 302 Certification of Scott Krenz
 EX-32.1 Section 906 Certification of Jerry Greenberg
 EX-32.2 Section 906 Certification of Stuart Moore
 EX-32.2 Section 906 Certification of Scott Krenz
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
      This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements included in this Quarterly Report, other than statements of historical facts, regarding our strategy, future operations, financial position, estimated revenues, projected costs, prospects, plans and objectives are forward-looking statements. When used in this Quarterly Report, the words “will,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We cannot guarantee future results, levels of activity, performance or achievements and you should not place undue reliance on our forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including the risks described below in “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Risk Factors” and elsewhere in this Quarterly Report. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or strategic investments. In addition, any forward-looking statements represent our expectation only as of the day this Quarterly Report was first filed with the SEC and should not be relied on as representing our expectations as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our expectations change.

1


Table of Contents

SAPIENT CORPORATION
CONSOLIDATED AND CONDENSED BALANCE SHEETS
                     
    March 31,   December 31,
    2005   2004
         
    (Unaudited)
    (In thousands,
    except share amounts)
ASSETS
Current assets:
               
 
Cash and cash equivalents
  $ 48,847     $ 66,779  
 
Marketable investments
    66,701       38,172  
 
Restricted cash
    3,138       3,168  
 
Accounts receivable, less allowance for doubtful accounts of $1,518 and $1,896, respectively
    49,539       51,278  
 
Unbilled revenues on contracts
    21,444       16,875  
 
Prepaid expenses and other current assets
    10,868       9,052  
             
   
Total current assets
    200,537       185,324  
Marketable investments
    44,261       64,006  
Restricted cash
    3,389       3,454  
Property and equipment, net
    17,466       14,612  
Intangible assets, net
    515       643  
Deferred tax asset
    797       815  
Other assets
    744       749  
             
   
Total assets
  $ 267,709     $ 269,603  
             
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
               
 
Accounts payable
  $ 5,970     $ 6,125  
 
Accrued expenses
    19,965       18,832  
 
Accrued restructuring costs, current portion
    10,328       10,560  
 
Accrued compensation
    16,250       17,722  
 
Income taxes payable
    4,269       4,116  
 
Deferred revenues on contracts
    7,200       9,285  
             
   
Total current liabilities
    63,982       66,640  
Accrued restructuring costs, net of current portion
    12,492       15,003  
Other long term liabilities
    2,238       2,027  
             
   
Total liabilities
    78,712       83,670  
             
Commitments and contingencies (Note 5)
               
Stockholders’ equity:
               
 
Preferred stock, par value $.01 per share, 5,000,000 authorized and none issued at March 31, 2005 and December 31, 2004
           
 
Common stock, par value $.01 per share, 200,000,000 shares authorized, 130,482,574 and 130,482,574 shares issued at March 31, 2005 and December 31, 2004, respectively
    1,304       1,304  
 
Additional paid-in capital
    478,052       477,669  
 
Treasury stock, at cost, 6,451,815 and 6,221,679 shares at March 31, 2005 and December 31, 2004, respectively
    (9,667 )     (7,251 )
 
Accumulated other comprehensive income
    3,036       4,090  
 
Accumulated deficit
    (283,728 )     (289,879 )
             
   
Total stockholders’ equity
    188,997       185,933  
             
   
Total liabilities and stockholders’ equity
  $ 267,709     $ 269,603  
             
The accompanying notes are an integral part of these Consolidated and Condensed Financial Statements.

2


Table of Contents

SAPIENT CORPORATION
CONSOLIDATED AND CONDENSED STATEMENTS OF OPERATIONS
                     
    Three Months Ended
    March 31,
     
    2005   2004
         
    (Unaudited)
    (In thousands, except
    per share amounts)
Revenues:
               
 
Service revenues
  $ 76,808     $ 58,878  
 
Reimbursable expenses
    3,546       2,179  
             
   
Total gross revenues
    80,354       61,057  
             
Operating expenses:
               
 
Project personnel costs, before reimbursable expenses
    45,974       36,326  
 
Reimbursable expenses
    3,546       2,179  
             
   
Total project personnel costs
    49,520       38,505  
 
Selling and marketing costs
    3,613       4,262  
 
General and administrative costs
    20,910       16,961  
 
Amortization of intangible assets
    129       129  
 
Stock-based compensation
    22       212  
             
   
Total operating expenses
    74,194       60,069  
             
Income from operations
    6,160       988  
Interest and other income (expense), net
    830       455  
             
Income before income taxes
    6,990       1,443  
Income tax provision
    839       148  
             
 
Net income
  $ 6,151     $ 1,295  
             
Basic net income per share
  $ 0.05     $ 0.01  
             
Diluted net income per share
  $ 0.05     $ 0.01  
             
Weighted average common shares
    124,179       122,325  
Weighted average dilutive common share equivalents
    5,312       5,001  
             
Weighted average common shares and dilutive common share equivalents
    129,491       127,326  
             
The accompanying notes are an integral part of these Consolidated and Condensed Financial Statements.

3


Table of Contents

SAPIENT CORPORATION
CONSOLIDATED AND CONDENSED STATEMENTS OF CASH FLOWS
                       
    Three Months Ended
    March 31,
     
    2005   2004
         
    (Unaudited)
    (In thousands)
Cash flows from operating activities:
               
 
Net income
  $ 6,151     $ 1,295  
 
Adjustments to reconcile net income to net cash used in operating activities:
               
   
Depreciation
    1,301       1,634  
   
Amortization of intangible assets
    129       129  
   
Stock-based compensation
    22       212  
   
Provision for (recovery of) allowance for doubtful accounts, net
    (327 )     (139 )
   
Changes in operating assets and liabilities:
               
     
Restricted cash
    (12 )     1,743  
     
Accounts receivable
    1,322       (5,420 )
     
Unbilled revenues on contracts
    (4,840 )     816  
     
Prepaid expenses and other current assets
    (1,906 )     387  
     
Other assets
    5       (172 )
     
Accounts payable
    (81 )     (983 )
     
Accrued expenses
    1,505       (681 )
     
Accrued restructuring costs
    (2,323 )     (4,671 )
     
Accrued compensation
    (1,316 )     2,982  
     
Income taxes payable
    185       40  
     
Deferred revenues on contracts
    (1,912 )     (2,035 )
     
Other long term liabilities
    224       493  
             
   
Net cash used in operating activities
    (1,873 )     (4,370 )
Cash flows from investing activities:
               
 
Purchases of property and equipment
    (4,621 )     (569 )
 
Sales and maturities of marketable investments
    18,474       29,200  
 
Purchases of marketable investments
    (27,612 )     (25,857 )
             
   
Net cash (used in) provided by investing activities
    (13,759 )     2,774  
Cash flows from financing activities:
               
 
Proceeds from stock option and purchase plans
    546       1,626  
 
Repurchases of common stock
    (2,604 )      
             
   
Net cash (used in) provided by financing activities
    (2,058 )     1,626  
             
Effect of exchange rate changes on cash and cash equivalents
    (242 )     411  
(Decrease) increase in cash and cash equivalents
    (17,932 )     441  
Cash and cash equivalents, at beginning of period
    66,779       67,592  
             
Cash and cash equivalents, at end of period
  $ 48,847     $ 68,033  
             
The accompanying notes are an integral part of these Consolidated and Condensed Financial Statements.

4


Table of Contents

SAPIENT CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS
1. Basis of Presentation
      The accompanying unaudited consolidated and condensed financial statements have been prepared by Sapient Corporation pursuant to the rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements and should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2004 included in the Company’s Annual Report on Form 10-K. The accompanying consolidated and condensed financial statements reflect all adjustments (consisting solely of normal, recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of results for the interim periods presented. The results of operations for the three months ended March 31, 2005 are not necessarily indicative of the results to be expected for any future period or the full fiscal year.
      Certain amounts in previously issued financial statements have been reclassified to conform to the current presentation.
      Unless the context requires otherwise, references in this Quarterly Report to “Sapient,” “the Company,” “we,” “us” or “our” refer to Sapient Corporation and its consolidated subsidiaries.
2. Net Income Per Share
      The following information presents the Company’s computation of basic and diluted net income per share for the periods presented in the consolidated and condensed statements of operations (in thousands, except per share data):
                   
    Three Months Ended
    March 31,
     
    2005   2004
         
Net income
  $ 6,151     $ 1,295  
Basic net income per share:
               
 
Weighted average common shares outstanding
    124,179       122,325  
             
 
Basic net income per share
  $ 0.05     $ 0.01  
             
Diluted net income per share:
               
 
Weighted average common shares outstanding
  $ 124,179     $ 122,325  
 
Dilutive common share equivalents
    5,312       5,001  
             
 
Weighted average common shares and dilutive common share equivalents
    129,491       127,326  
             
 
Diluted net income per share
  $ 0.05     $ 0.01  
             
      Excluded from the above computations of weighted average common shares and dilutive common share equivalents for diluted net income per share were options to purchase 7.5 million and 9.4 million shares of common stock for the three months ended March 31, 2005 and 2004, respectively, because their inclusion would have an anti-dilutive effect on diluted net income per share.
3. Stock-Based Compensation
      Statement of Financial Accounting Standards No. 123 (SFAS 123), “Accounting for Stock-Based Compensation,” requires that companies either recognize compensation expense for grants of stock options and other equity instruments issued to employees based on fair value, or provide pro forma disclosure of net income (loss) and net income (loss) per share in the notes to the financial statements. At March 31, 2005, the

5


Table of Contents

SAPIENT CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
Company has eight stock-based compensation plans, which are described more fully in the Company’s Annual Report on Form 10-K. The Company accounts for awards to employees under those plans under the recognition and measurement principles of Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees,” and related interpretations. Accordingly, no compensation cost has been recognized under SFAS 123 for the Company’s employee stock option plans. Had compensation cost for the awards under those plans been determined based on the grant date fair values, consistent with the method required under SFAS 123, the Company’s net income (loss) and net income (loss) per share would have been adjusted to the pro forma amounts indicated below:
                   
    Three Months Ended
    March 31,
     
    2005   2004
         
    (In thousands, except
    per share amounts)
Net income as reported
  $ 6,151     $ 1,295  
 
Add back: Stock-based compensation, included in net income, as reported
    22       212  
 
Deduct: Stock-based employee compensation expense determined under fair value based method for all awards
    (2,936 )     (6,078 )
             
 
Pro forma net income (loss)
  $ 3,237     $ (4,571 )
             
Basic net income (loss) per share
               
 
As reported
  $ 0.05     $ 0.01  
 
Pro forma
  $ 0.03     $ (0.04 )
Diluted net income (loss) per share
               
 
As reported
  $ 0.05     $ 0.01  
 
Pro forma
  $ 0.02     $ (0.04 )
      Project personnel costs (before reimbursable expenses), and general and administrative costs appearing in the consolidated and condensed statements of operations are shown exclusive of the following stock-based compensation amounts:
                 
    For the Three
    Months Ended
    March 31,
     
    2005   2004
         
Project personnel costs, before reimbursable expenses
  $ 9     $ 190  
General and administrative costs
    13       22  
             
Stock-based compensation
  $ 22     $ 212  
             

6


Table of Contents

SAPIENT CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
4. Comprehensive Income (Loss)
      Statement of Financial Accounting Standards No. 130, “Reporting Comprehensive Income” (SFAS 130), establishes standards for reporting comprehensive income. Comprehensive income includes net income as currently reported under generally accepted accounting principles and also considers the effect of additional economic events that are not required to be recorded in determining net income but rather are reported as a separate component of stockholders’ equity. The Company reports foreign currency translation gains and losses and unrealized gains and losses on investments as components of comprehensive income. The components of comprehensive income are presented below for the periods presented in the consolidated and condensed statements of operations:
                 
    For the Three
    Months Ended
    March 31,
     
    2005   2004
         
Net income
  $ 6,151     $ 1,295  
Foreign currency translation (loss) gain
    (744 )     1,068  
Unrealized (loss) gain on investments
    (310 )     26  
             
Comprehensive income
  $ 5,097     $ 2,389  
             
5. Contingent and Other Liabilities
      The Company has certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. The Company is subject to various legal claims totaling approximately $1.8 million and various administrative audits, each of which has arisen in the ordinary course of business. The Company has an accrual at March 31, 2005 of approximately $0.2 million related to these items. The Company intends to defend these matters vigorously, however the ultimate outcome of these items is uncertain and the potential loss, if any, may be significantly higher or lower than the amounts that the Company has previously accrued.
6. Restructuring and Other Related Charges
      As a result of the decline in the demand for advanced technology consulting services that began in the second half of 2000, and the resulting decline in our service revenues in 2001 and 2002, the Company restructured its workforce and operations in 2001, 2002 and the second half of 2003.
      The Company recorded restructuring and other related charges of approximately $170.7 million through December 31, 2004. The restructuring charges relate to the termination of employees and decreases in estimated sublease income in connection with the restructuring plans previously announced. The restructuring plans also resulted in discontinuing operations and closing offices where we had excess office space. Estimated costs for the consolidation of facilities include contractual rental commitments or lease buy-outs for office space vacated and related costs, offset by estimated sublease income.
      The Company did not record restructuring and other related charges during the three month periods ended March 31 2005 and 2004.

7


Table of Contents

SAPIENT CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
      Accruals for restructuring and other related activities as of, and for the three months ended March 31, 2005 and 2004, were as follows (in thousands):
                         
    Workforce   Facilities   Total
             
Balance, December 31, 2004
  $ 11     $ 25,552     $ 25,563  
Adjustment
    (11 )           (11 )
Non-cash, utilized
          (420 )     (420 )
Cash utilized
          (2,312 )     (2,312 )
                   
Balance, March 31, 2005
  $     $ 22,820     $ 22,820  
                   
Current accrued restructuring costs
                  $ 10,328  
                   
Non-current accrued restructuring costs
                  $ 12,492